SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001485003-17-000032
Filing Date
2017-04-07
Accepted
2017-04-07 07:36:28
Documents
4
Period of Report
2017-05-19
Effectiveness Date
2017-04-07

Document Format Files

Seq Description Document Type Size
1 DEF 14A ebio2017proxystatement.htm DEF 14A 597025
2 ebiologoa12.jpg GRAPHIC 89522
3 hurleysignature.jpg GRAPHIC 48456
4 hurleysignaturea01.jpg GRAPHIC 48456
  Complete submission text file 0001485003-17-000032.txt   854841
Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Eleven Biotherapeutics, Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36296 | Film No.: 17747623
SIC: 2834 Pharmaceutical Preparations